Gene · 6282
Papers1,617
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,617
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of potential characteristic genes in sepsis utilizing RNA sequencing and gene silence. | BMC Immunol | 2025 | 41444533 | PubTator, text mining | PubMed |
| Exploring the expression and prognostic roles of LAD1 in lung adenocarcinoma. | Sci Rep | 2025 | 41423496 | PubTator, text mining | PubMed |
| The S100 protein family in bladder cancer: mechanisms, clinical value, and targeted therapeutic prospects. | Front Oncol | 2025 | 41404073 | PubTator, text mining | PubMed |
| Senescence-related gene signatures in Crohn's disease: integrating bulk and single-cell RNA sequencing analysis. | Sci Rep | 2025 | 41286494 | PubTator, text mining | PubMed |
| ER stress upregulates S100A11 in steatohepatitis models via epigenetic modifications within the lipotoxicity-influenced enhancer. | J Clin Invest | 2025 | 41027000 | PubTator, text mining | PubMed |
| Identifying survival subtypes with autoencoder using multiple types of high-dimensional genomic data from studies of glioblastoma multiforme. | Brief Bioinform | 2025 | 41016009 | PubTator, text mining | PubMed |
| Mapping the Proteomic Landscape of Pancreatic Cancer: Prognostic Insights and Subtype Stratification. | Cancer Res Commun | 2025 | 41003647 | PubTator, text mining | PubMed |
| Integrative single-cell and machine learning approach to characterize immunogenic cell death and tumor microenvironment in LUAD. | J Transl Med | 2025 | 40993741 | PubTator, text mining | PubMed |
| Dual RNA isolation from blood: an optimized protocol for host and bacterial RNA purification for dual RNA-sequencing analysis in whole blood sepsis samples. | Microb Genom | 2025 | 40965975 | PubTator, text mining | PubMed |
| Identification of Novel Protein Biomarkers for Myasthenia Gravis by Integrating Human Proteomics with Genetic Instruments. | J Proteome Res | 2025 | 40919881 | PubTator, text mining | PubMed |
| Corrigendum to "Downregulation of S100A11 promotes T cell infiltration by regulating cancer-associated fibroblasts in prostate cancer" [Int. Immunopharmacol. 128 (2024) 111323]. | Int Immunopharmacol | 2025 | 40883196 | PubTator, text mining | PubMed |
| The Role of Extracellular Vesicles in Mediating Signaling in Biliary Epithelial Cell Activation and Cholangiopathies. | Cells | 2025 | 40862753 | PubTator, text mining | PubMed |
| Mechanistic Insights and Clinical Implications of ELK1 in Solid Tumors: A Narrative Review. | Cells | 2025 | 40862737 | PubTator, text mining | PubMed |
| Unveiling the protein landscape for early detection of colorectal precancerous lesions. | Clin Proteomics | 2025 | 40841878 | PubTator, text mining | PubMed |
| Comparative analysis of S100A10 and S100A11 in MASLD and hepatic cancer development revealed a tumor suppressive role for S100A10. | Cell Death Dis | 2025 | 40841353 | PubTator, text mining | PubMed |
| Machine Learning-Based Integration of Single-Cell and Bulk Transcriptome Reveals Coagulation Signature and Phenotypic Heterogeneity in Hepatocellular Carcinoma. | IET Syst Biol | 2025 | 40820328 | PubTator, text mining | PubMed |
| Effect of ultrasound-microbubble exposure on acute myeloid leukemia cancer cell proteome. | Sci Rep | 2025 | 40813407 | PubTator, text mining | PubMed |
| E3 ubiquitin ligase FBXW11-mediated downregulation of S100A11 promotes sensitivity to PARP inhibitor in ovarian cancer. | J Pharm Anal | 2025 | 40747341 | PubTator, text mining | PubMed |
| Lactylation-related gene signatures identify glioma molecular subtypes with prognostic, immunological, and therapeutic implications. | Front Oncol | 2025 | 40740857 | PubTator, text mining | PubMed |
| Integrative spatial and single-cell transcriptomics elucidate programmed cell death-driven tumor microenvironment dynamics in hepatocellular carcinoma. | Front Immunol | 2025 | 40740783 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6282/papers?page=3